Accordingly, there is a compelling need to develop a non-invasive, cost-effective method for the detection of subclinical disease and vulnerable plaques in patients. Although carotid intima-media thickness (C-IMT) is currently used as a surrogate marker of atherosclerosis, recent advances in contrast ultrasound techniques are promising and may serve to characterize intra-plaque angiogenesis. 6 Based on clinical observations and published reports, the presence of neovascularization appears to be a distinct marker of plaque instability and vulnerability. 7, 8 Importantly, and subsequent to our initial submission of this manuscript, two intriguing clinical manuscripts have been published. The first of these manuscripts described the role of angiogenesis in patients with ischemic symptoms, 8 while the second report highlighted the therapeutic role of statins for the treatment of unstable, highly vascular carotid artery plaques. 9 In the first of these two recent articles the authors continued a theme they developed in 1999, which described the relationship between increased carotid plaque neovascularization and symptomatic disease. 7 In their most recent communication in 2007, Dunmore and McCarthy et al stated that the symptomatic carotid plaques have similarities with the immature microvessels observed in tumors and healing wounds. The authors hypothesized that the presence of these immature vessels contributed to the instability of the plaque based on the porosity of the immature vessels, thus contributing to plaque instability. Further, they suggested that these abnormal, immature vessels may serve as future targets for therapeutic intervention. 8 The second of the two manuscripts, Koutouzis et al noted a reduction of intra-plaque angiogenesis in patients who received statin therapy for a minimum of 3 months prior to a surgical endarterectomy. 9 Therefore, the goal of our study was to demonstrate that contrast-enhanced carotid ultrasound (CECU) is a novel, non-invasive method for detecting intra-plaque neovascularization.
Methods

Patient enrollment and ultrasound examination methods
Patients were referred for carotid ultrasound testing based on clinical indications (symptomatic cerebrovascular disease, preventative exams). At the time of the examination, patients were asked to enroll in our clinical research study (Rush University Medical Center, IRB #2, ORA# 01062001, initiated in 2001). All enrolled patients received a standard carotid duplex ultrasound examination followed by the contrast portion of the study. The final clinical reports were independently generated from either the Vascular Laboratory or the Cardiovascular Laboratory at Rush University using previously established and published criteria.
The contrast ultrasound injections were identified as the research component. From the enrolled individuals, a total of 15 patients underwent carotid endarterectomy and two patients had bilateral endarterectomy surgery, thus establishing a total of 17 cases. The patient's baseline demographics, including medical history, statin use, and symptoms, were recorded (see Table 2 ).
All patients received a carotid ultrasound examination with the GE VIVID 7 or ATL HDI 5000 ultrasound machine. The CECU imaging protocol was performed using an ultrasound contrast agent, Optison™ (perflutren protein type-A microspheres; GE Health Care, Milwaukee, WI, USA) per our standard protocol. 10 Optison is an FDA-approved ultrasound contrast agent that is used for enhancement of the cardiac chambers during echocardiography. In 2000, The American Society of Echocardiography published a guideline manuscript on the use of ultrasound contrast agents. 11 The ultrasound contrast agent Optison, supplied as 3 ml vials, was diluted with 7 ml of saline, creating a total of 10 ml of infusate. The contrast agent was injected via a peripheral vein as a bolus of 0.5-1.0 ml followed by a saline bolus of 2-3 ml of saline. The appearance of the contrast effect was observed inside the carotid lumen within 15-30 seconds following the injection sequence. The ultrasound studies were recorded on VHS videotape and/or stored digitally.
A trained sonographer using a linear array, a vascular ultrasound probe equipped with harmonic software, was used to perform the ultrasound studies. Following completion of the routine non-contrast carotid ultrasound examination the mechanical index was lowered to the lowest possible level and the gain with time gain compensation (TGC) and compression adjusted to provide the highest contrast effect. The ultrasound systems consisted of an ATL/Philips HDI 5000 unit equipped with a 7-4 linear array probe using general imaging (GI) and harmonic software. For the contrast studies, the MI was adjusted for maximum contrast effect (0.06-0.10). The second ultrasound unit used was a GE VIVID7 Dimension with a 7L probe and harmonic imaging software. For the contrast injections, the mechanical index (MI) was adjusted to 0.18-0.20 for maximum contrast effect.
The surgeon reviewed the contrast ultrasound images prior to performing endarterectomy surgery. There was no direct ultrasound imaging performed during the surgery. The pathologist was blinded to the CECU images when she performed the histology sample preparations.
Visual ultrasound analysis
The CECU images of carotid artery plaque neovascularization were graded by an experienced ultrasound reader (SF) and two co-investigators (FS and PB). The value assigned to the degree of neovascularization for each study was the average of a consensus grading among the readers. The grading system for the presence of neovascularization was as follows. A grade of 0 was used to indicate no appearance of neovascularization within the plaque. A grade 3 was reserved for images that revealed the presence of a pulsating, arterial vessel within the plaque (implying arteriogenesis). Grade 1 revealed a limited appearance of neovascularization within the plaque and Grade 2 was considered moderate neovascularization with less neovascularization than noted in grade 3 and more than that of grade 1. Of note, in the course of reviewing the surgical specimens, the carotid artery vessel wall and adventitial layers were not routinely dissected at the time of the surgical endarterectomy and therefore the neovascularization grade consisted of the vasculature within the plaque, which included the intima and media. Consensus grading was used to resolve reader variation regarding plaque neovascularization.
Histologic analysis of plaque specimens
Atherosclerotic plaque specimens obtained from carotid endarterectomy were routinely processed in surgical pathology. In addition to hematoxylin and eosin stains of formalin-fixed paraffin-embedded tissue, 4m sections were stained with the following immunohistochemical markers: CD31, CD34, von Willebrand factor, CD68, and mast cell tryptase. Prussian blue staining was performed to highlight hemosiderin. Sections from each carotid plaque specimen were evaluated for degree of vascularity employing CD31, CD34, von Willebrand factor, and hemosiderin as markers of vascularity. Sections from each specimen were also evaluated for the presence and number of macrophages, using CD68 as a macrophage marker, and mast cells, using mast cell tryptase as a mast cell marker. Six sets of stained slides were examined microscopically for evidence of neovascularization and inflammation. The neovascularization seen on the microscopic sections was graded using a method similar to that employed by Jeziorska et al. 12 The findings from each slide were assigned numerical values based on the prominence of the neovascular channels present: none ϭ 0; minimal ϭ 0-1; moderate ϭ 1-2; extensive ϭ 2-3.
Analysis
The average numerical value for the carotid plaque neovascularization determined from the CECU examination was correlated with the numeric value for neovascularization obtained from the histology specimens. The statistical analysis used was the Spearman rank method. Table 1 provides a numerical summary of the grading of neovascularization seen both on CECU and histopathology for all 17 cases associated with the estimated degree of carotid artery stenosis determined from the clinical duplex examination. Table 2 lists the patient demographics and the associated carotid duplex ultrasound results.
Results
Employing Spearman's rank method, comparison of the neovascularization values obtained from CECU 
Figure 2
Sequence of images obtained following the intravenous injection of ultrasound contrast. Note the presence of intra-plaque neovascularization in the sequential frames (Grade 2.5, extensive neovascularization). The patient was a 71-year-old man with no history of symptomatic cerebrovascular disease.
Figure 3
Marked neovascularization within the carotid artery plaque following intravenous ultrasound contrast agent injection (Grade 3, 'arteriogenesis'). These images were obtained at the bedside prior to carotid endarterectomy surgery. Of note, the patient experienced active, ongoing cerebrovascular events (serial TIAs) and was diagnosed with NIDDM and hyperlipidemia. At the time of these images, he was not treated with statins and he continued to smoke cigarettes.
Figure 4
This patient presented with symptomatic cerebrovascular disease (TIA). He was diagnosed with elevated fasting blood sugar, hyperlipidemia and low HDL cholesterol. He underwent carotid endarterectomy surgery and was subsequently treated with statins, aspirin, and peroxisome proliferator-activated receptor (PPAR) medications. He has been without symptoms since surgery. The degree of intra-plaque neovascularization was graded as Grade 2.
Figure 5
This carotid ultrasound examination was obtained from a woman with a history of coronary artery disease and hyperlipidemia. Despite the carotid endarterectomy surgery, she experienced symptomatic cerebrovascular events (TIA) and continued to smoke cigarettes.
with those obtained from the CD31-stained surgical histopathology specimens revealed a correlation of 0.68 (p-value ϭ 0.002 and 95% confidence interval). Additional correlative comparisons were performed using a composite of CD34, von Willebrand factor, and hemosiderin which revealed a correlation of 0.50, again by Spearman's rank method.
Discussion
The purpose of the present study was to test the hypothesis that the neovascularization seen on CECU correlates with the neovascularization seen on histologic examination of carotid plaque tissue specimens. Based on 17 prospective clinical cases, the correlation between the CECU neovascularization and the corresponding histologic analysis of neovascularization using CD31-stained specimens was 0.68 by Spearman's rank method.
The importance of developing a non-invasive imaging method to assess atherosclerosis and vulnerable plaques is highly clinically relevant. In 2004, Moreno et al. referring to the mechanism leading to atherosclerotic plaque rupture, stated that newer potent imaging technologies, including contrast ultrasound and MRI, may allow one to identify the neovasculature associated with unstable plaques. 13 Therefore, these initial CECU studies provide direct evidence that atherosclerotic plaque neovascularization, a prominent feature of the earliest stages of atherosclerosis, may be detected and quantified using non-invasive methods.
One consistent and unifying observation noted from these studies is that angiogenesis is associated with the development of atherosclerosis, a finding similar to that in cancer research, which was noted by Folkman in 1971. 14 As inflammatory events unfold within the vessel wall, angiogenic vessels originating from the adventitial surface of the blood vessel are induced via vascular endothelial growth factor (VEGF) proteins. These nutrient-deprived, immature vessels arise, often without pericyte development, producing 'leaky' intraplaque vessels resulting in additional vessel wall inflammation and ischemia, which in turn causes the release of excessive angiogenic factors and the subsequent overgrowth of vasa vasorum. The increased cellular infiltration and resultant inflammation result in the migration of cellular components (i.e. smooth muscle cells, leukocytes, monocyte derived macrophages), which lead to decreased oxygen tension within the arterial wall.
With regard to comparing imaging modalities used for the characterization of atherosclerotic plaque constituency, CECU imaging provides a simple, direct, and effective imaging method capable of detecting neovascular changes within the atherosclerotic carotid plaque emblematic of systemic disease. The practicality of performing these studies is based on the established base (4.6 million carotid ultrasound outpatient exams are performed annually 15 ) and the cost-effectiveness of performing the examination. Importantly, the use of microvascular indicators (ultrasound contrast agents), serving as intravascular indicators, provides an unparalleled level of spatial and temporal microvascular perfusion resolution when compared to MSCT and MRI/MRA. Additionally, the possibility of using realtime microvascular imaging to detect disease and potentially monitor therapy is intriguing.
Limitations
The Spearman rank correlation value of 0.68 between the contrast-enhanced ultrasound visualization of plaque neovascularization and the histology may be improved after correcting for sampling biases. For example, the contrast-enhanced ultrasound imaging data were acquired from a specific volume and spatial orientation. The tissue specimens, however, were not re-oriented based on the ultrasound imaging plane. Furthermore, only a single, 4-m slice was taken from each carotid plaque and used for the comparative analysis. This sampling bias may have reduced the correlation value between the neovascularization observed on the ultrasound images and correlative extent of neovascularization within the tissue specimens. Future comparative studies will include a spatial orientation for pathologic comparison and 3-D/4-D ultrasound imaging.
Another limitation of the present study is the subjectivity in grading both the ultrasound images and the histopathology samples. We are developing computeraided programs to analyze and quantify plaque neovascularization (perfusion) with CECU, similar to systems developed and validated for the quantification of myocardial perfusion with contrast echocardiography. 5, 16 In summary, based on our initial data, in order to extend these studies into the clinics, it will be important to perform larger clinical trials in order to confirm these findings. If validated, CECU imaging may be used as a routine method to monitor the progression and regression of atherosclerosis in vulnerable patients. 
